Open AccessEfficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer
Author(s) -
Ying Wu,
Zhe Wei,
Yu He,
Roderich E. Schwarz,
David Smith,
Guang Xia,
Chang Hua Zhang
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i21.3309
Subject(s) - medicine , oxaliplatin , folinic acid , capecitabine , hazard ratio , propensity score matching , surgery , oncology , gastroenterology , chemotherapy , cancer , fluorouracil , colorectal cancer , confidence interval
To compare the efficacy of capecitabine and oxaliplatin (XELOX) with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX6) in gastric cancer patients after D2 dissection.